Coronavirus News Roundup: Moderna’s Vaccine Elicits Immune Response in Older Adults, MJH Life Sciences’ COVID-19 Coalition Survey Results

October 2, 2020

Here's the coronavirus-related news from this week that you should know.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 34,423,675 individuals worldwide, and approximately 7.3 million Americans. The latest COVID-19 related news includes Moderna’s interim analysis results of its vaccine candidate, and MJH Life Sciences’ COVID-19 Coalition releasing survey results on the most pressing pandemic-related issues.

Here’s a roundup of the latest coronavirus-related news:

Moderna COVID-19 Vaccine Elicits Immune Response in Older Adults

Moderna’s COVID-19 vaccine candidate induced immune responses in older adults, according to a second interim analysis of a phase 1 study evaluating safety and immunogenicity.

Read more

Experts Weigh in on Latest COVID-19 Pandemic News

The MJH Life Sciences COVID-19 Coalition is a partnership with 10 nationally recognized experts in infectious disease, public health, epidemiology, and virology, who work to generate the most accurate, up-to-the-minute information on the pandemic's ever-evolving impact on health care professionals and the patients they treat through live, biweekly webinar events, white papers, and surveys.

View more COVID-19 Coalition events here

Study: Initial SARS-CoV-2 Viral Loads Decreased As Pandemic Progressed

Results of a study based in Detroit, Michigan reported that the initial viral load of SARS-CoV-2 in nasopharyngeal samples has been decreasing throughout the pandemic’s progression.

Read more